カテゴリー： QYResearch, 世界, 医療/バイオ

世界の院内感染検査市場インサイト及び予測（分子診断、血液検査、尿検査）

◆英語タイトル：Global Hospital Acquired Infection Testing Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09235 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：105 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、院内感染検査のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に院内感染検査の世界市場のxxx％を占める「分子診断」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「尿路感染症」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
院内感染検査の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの院内感染検査市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

院内感染検査のグローバル主要企業には、BioMerieux、Abbott Laboratories、Alere、Roche、Siemens Healthcare、Becton Dickenson、Cepheid、Roche Holding AG、Thermo Fisher Scientific、Seegene、Qiagenなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

院内感染検査市場は、種類と用途によって区分されます。世界の院内感染検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
分子診断、血液検査、尿検査

【用途別セグメント】
尿路感染症、肺炎、手術部位感染症、菌血症、その他院内感染症

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 院内感染検査製品概要
- 種類別市場（分子診断、血液検査、尿検査）
- 用途別市場（尿路感染症、肺炎、手術部位感染症、菌血症、その他院内感染症）
- 調査の目的
・エグゼクティブサマリー
- 世界の院内感染検査販売量予測2017-2028
- 世界の院内感染検査売上予測2017-2028
- 院内感染検査の地域別販売量
- 院内感染検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別院内感染検査販売量
- 主要メーカー別院内感染検査売上
- 主要メーカー別院内感染検査価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（分子診断、血液検査、尿検査）
- 院内感染検査の種類別販売量
- 院内感染検査の種類別売上
- 院内感染検査の種類別価格
・用途別市場規模（尿路感染症、肺炎、手術部位感染症、菌血症、その他院内感染症）
- 院内感染検査の用途別販売量
- 院内感染検査の用途別売上
- 院内感染検査の用途別価格
・北米市場
- 北米の院内感染検査市場規模（種類別、用途別）
- 主要国別の院内感染検査市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの院内感染検査市場規模（種類別、用途別）
- 主要国別の院内感染検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の院内感染検査市場規模（種類別、用途別）
- 主要国別の院内感染検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の院内感染検査市場規模（種類別、用途別）
- 主要国別の院内感染検査市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの院内感染検査市場規模（種類別、用途別）
- 主要国別の院内感染検査市場規模（トルコ、サウジアラビア）
・企業情報
BioMerieux、Abbott Laboratories、Alere、Roche、Siemens Healthcare、Becton Dickenson、Cepheid、Roche Holding AG、Thermo Fisher Scientific、Seegene、Qiagen
・産業チェーン及び販売チャネル分析
- 院内感染検査の産業チェーン分析
- 院内感染検査の原材料
- 院内感染検査の生産プロセス
- 院内感染検査の販売及びマーケティング
- 院内感染検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 院内感染検査の産業動向
- 院内感染検査のマーケットドライバー
- 院内感染検査の課題
- 院内感染検査の阻害要因
・主な調査結果

Market Analysis and Insights: Global Hospital Acquired Infection Testing Market
The global Hospital Acquired Infection Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Molecular Diagnostics accounting for % of the Hospital Acquired Infection Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Urinary Tract Infections segment is altered to an % CAGR throughout this forecast period.
China Hospital Acquired Infection Testing market size is valued at US$ million in 2021, while the North America and Europe Hospital Acquired Infection Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Hospital Acquired Infection Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital Acquired Infection Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital Acquired Infection Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital Acquired Infection Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital Acquired Infection Testing market.
Global Hospital Acquired Infection Testing Scope and Market Size
Hospital Acquired Infection Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infection Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Molecular Diagnostics
Blood Tests
Urinalysis
Segment by Application
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
By Company
BioMerieux
Abbott Laboratories
Alere
Roche
Siemens Healthcare
Becton Dickenson
Cepheid
Roche Holding AG
Thermo Fisher Scientific
Seegene
Qiagen
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Infection Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Molecular Diagnostics
1.2.3 Blood Tests
1.2.4 Urinalysis
1.3 Market by Application
1.3.1 Global Hospital Acquired Infection Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Urinary Tract Infections
1.3.3 Pneumonia
1.3.4 Surgical Site Infections
1.3.5 Bloodstream Infections
1.3.6 Other Hospital Infections
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infection Testing Market Perspective (2017-2028)
2.2 Hospital Acquired Infection Testing Growth Trends by Region
2.2.1 Hospital Acquired Infection Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hospital Acquired Infection Testing Historic Market Size by Region (2017-2022)
2.2.3 Hospital Acquired Infection Testing Forecasted Market Size by Region (2023-2028)
2.3 Hospital Acquired Infection Testing Market Dynamics
2.3.1 Hospital Acquired Infection Testing Industry Trends
2.3.2 Hospital Acquired Infection Testing Market Drivers
2.3.3 Hospital Acquired Infection Testing Market Challenges
2.3.4 Hospital Acquired Infection Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infection Testing Players by Revenue
3.1.1 Global Top Hospital Acquired Infection Testing Players by Revenue (2017-2022)
3.1.2 Global Hospital Acquired Infection Testing Revenue Market Share by Players (2017-2022)
3.2 Global Hospital Acquired Infection Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Acquired Infection Testing Revenue
3.4 Global Hospital Acquired Infection Testing Market Concentration Ratio
3.4.1 Global Hospital Acquired Infection Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infection Testing Revenue in 2021
3.5 Hospital Acquired Infection Testing Key Players Head office and Area Served
3.6 Key Players Hospital Acquired Infection Testing Product Solution and Service
3.7 Date of Enter into Hospital Acquired Infection Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Acquired Infection Testing Breakdown Data by Type
4.1 Global Hospital Acquired Infection Testing Historic Market Size by Type (2017-2022)
4.2 Global Hospital Acquired Infection Testing Forecasted Market Size by Type (2023-2028)
5 Hospital Acquired Infection Testing Breakdown Data by Application
5.1 Global Hospital Acquired Infection Testing Historic Market Size by Application (2017-2022)
5.2 Global Hospital Acquired Infection Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hospital Acquired Infection Testing Market Size (2017-2028)
6.2 North America Hospital Acquired Infection Testing Market Size by Type
6.2.1 North America Hospital Acquired Infection Testing Market Size by Type (2017-2022)
6.2.2 North America Hospital Acquired Infection Testing Market Size by Type (2023-2028)
6.2.3 North America Hospital Acquired Infection Testing Market Share by Type (2017-2028)
6.3 North America Hospital Acquired Infection Testing Market Size by Application
6.3.1 North America Hospital Acquired Infection Testing Market Size by Application (2017-2022)
6.3.2 North America Hospital Acquired Infection Testing Market Size by Application (2023-2028)
6.3.3 North America Hospital Acquired Infection Testing Market Share by Application (2017-2028)
6.4 North America Hospital Acquired Infection Testing Market Size by Country
6.4.1 North America Hospital Acquired Infection Testing Market Size by Country (2017-2022)
6.4.2 North America Hospital Acquired Infection Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hospital Acquired Infection Testing Market Size (2017-2028)
7.2 Europe Hospital Acquired Infection Testing Market Size by Type
7.2.1 Europe Hospital Acquired Infection Testing Market Size by Type (2017-2022)
7.2.2 Europe Hospital Acquired Infection Testing Market Size by Type (2023-2028)
7.2.3 Europe Hospital Acquired Infection Testing Market Share by Type (2017-2028)
7.3 Europe Hospital Acquired Infection Testing Market Size by Application
7.3.1 Europe Hospital Acquired Infection Testing Market Size by Application (2017-2022)
7.3.2 Europe Hospital Acquired Infection Testing Market Size by Application (2023-2028)
7.3.3 Europe Hospital Acquired Infection Testing Market Share by Application (2017-2028)
7.4 Europe Hospital Acquired Infection Testing Market Size by Country
7.4.1 Europe Hospital Acquired Infection Testing Market Size by Country (2017-2022)
7.4.2 Europe Hospital Acquired Infection Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Infection Testing Market Size (2017-2028)
8.2 Asia-Pacific Hospital Acquired Infection Testing Market Size by Type
8.2.1 Asia-Pacific Hospital Acquired Infection Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Hospital Acquired Infection Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Hospital Acquired Infection Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Hospital Acquired Infection Testing Market Size by Application
8.3.1 Asia-Pacific Hospital Acquired Infection Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Hospital Acquired Infection Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Hospital Acquired Infection Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Hospital Acquired Infection Testing Market Size by Region
8.4.1 Asia-Pacific Hospital Acquired Infection Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Hospital Acquired Infection Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hospital Acquired Infection Testing Market Size (2017-2028)
9.2 Latin America Hospital Acquired Infection Testing Market Size by Type
9.2.1 Latin America Hospital Acquired Infection Testing Market Size by Type (2017-2022)
9.2.2 Latin America Hospital Acquired Infection Testing Market Size by Type (2023-2028)
9.2.3 Latin America Hospital Acquired Infection Testing Market Share by Type (2017-2028)
9.3 Latin America Hospital Acquired Infection Testing Market Size by Application
9.3.1 Latin America Hospital Acquired Infection Testing Market Size by Application (2017-2022)
9.3.2 Latin America Hospital Acquired Infection Testing Market Size by Application (2023-2028)
9.3.3 Latin America Hospital Acquired Infection Testing Market Share by Application (2017-2028)
9.4 Latin America Hospital Acquired Infection Testing Market Size by Country
9.4.1 Latin America Hospital Acquired Infection Testing Market Size by Country (2017-2022)
9.4.2 Latin America Hospital Acquired Infection Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Infection Testing Market Size (2017-2028)
10.2 Middle East & Africa Hospital Acquired Infection Testing Market Size by Type
10.2.1 Middle East & Africa Hospital Acquired Infection Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Hospital Acquired Infection Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Hospital Acquired Infection Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Hospital Acquired Infection Testing Market Size by Application
10.3.1 Middle East & Africa Hospital Acquired Infection Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Hospital Acquired Infection Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Hospital Acquired Infection Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Hospital Acquired Infection Testing Market Size by Country
10.4.1 Middle East & Africa Hospital Acquired Infection Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Hospital Acquired Infection Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BioMerieux
11.1.1 BioMerieux Company Details
11.1.2 BioMerieux Business Overview
11.1.3 BioMerieux Hospital Acquired Infection Testing Introduction
11.1.4 BioMerieux Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.1.5 BioMerieux Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Hospital Acquired Infection Testing Introduction
11.2.4 Abbott Laboratories Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 Alere
11.3.1 Alere Company Details
11.3.2 Alere Business Overview
11.3.3 Alere Hospital Acquired Infection Testing Introduction
11.3.4 Alere Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.3.5 Alere Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Hospital Acquired Infection Testing Introduction
11.4.4 Roche Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.4.5 Roche Recent Developments
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Hospital Acquired Infection Testing Introduction
11.5.4 Siemens Healthcare Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.5.5 Siemens Healthcare Recent Developments
11.6 Becton Dickenson
11.6.1 Becton Dickenson Company Details
11.6.2 Becton Dickenson Business Overview
11.6.3 Becton Dickenson Hospital Acquired Infection Testing Introduction
11.6.4 Becton Dickenson Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.6.5 Becton Dickenson Recent Developments
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Hospital Acquired Infection Testing Introduction
11.7.4 Cepheid Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.7.5 Cepheid Recent Developments
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Details
11.8.2 Roche Holding AG Business Overview
11.8.3 Roche Holding AG Hospital Acquired Infection Testing Introduction
11.8.4 Roche Holding AG Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.8.5 Roche Holding AG Recent Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Hospital Acquired Infection Testing Introduction
11.9.4 Thermo Fisher Scientific Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.9.5 Thermo Fisher Scientific Recent Developments
11.10 Seegene
11.10.1 Seegene Company Details
11.10.2 Seegene Business Overview
11.10.3 Seegene Hospital Acquired Infection Testing Introduction
11.10.4 Seegene Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.10.5 Seegene Recent Developments
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Hospital Acquired Infection Testing Introduction
11.11.4 Qiagen Revenue in Hospital Acquired Infection Testing Business (2017-2022)
11.11.5 Qiagen Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の院内感染検査市場インサイト及び予測（分子診断、血液検査、尿検査）(Global Hospital Acquired Infection Testing Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の院内感染検査市場インサイト及び予測（分子診断、血液検査、尿検査）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp